Stem cell therapy for neonatal hypoxic-ischemic encephalopathy

Frontiers in Neurology

Volumn 5 AUG, Issue , 2014, Pages

  Gonzales Portillo, Gabriel S ^a   Reyes, Stephanny ^a   Aguirre, Daniela ^a   Pabon, Mibel M ^a   Borlongan, Cesar V ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cerebral palsy; Combination therapy; Hypothermia; Stem cells; Translational research

Indexed keywords

ERYTHROPOIETIN; HELIUM;

ARTICLE; CEREBRAL PALSY; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); DISEASE MODEL; ENCEPHALOMALACIA; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INDUCED HYPOTHERMIA; NEONATAL HYPOXIC ISCHEMIC ENCEPHALOPATHY; NERVE CELL PLASTICITY; NEUROPROTECTION; NEWBORN; NEWBORN DISEASE; NONHUMAN; OUTCOME ASSESSMENT; PROGNOSIS; SAFETY; STEM CELL TRANSPLANTATION; TRANSLATIONAL RESEARCH;

EID: 84906491479     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00147     Document Type: Article

References (159)

1. Vannucci R. Hypoxia Ischemia: Pathogenesis and Neuropathology. St. Louis, MO: Mosby (1997).
2. Selway LD. State of the science: hypoxic ischemic encephalopathy and hypothermic intervention for neonates. Adc Neonatal Care (2010) 10:60-6. doi: 10.1097/ANC.0b013e3181d54b30
3. Nelson KB. Neonatal encephalopathy: etiology and outcome. Dev Med Child Neurol (2005) 47:292. doi:10.1017/S0012162205000563
4. Nelson KB, Leviton A. Hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med (2006) 354:1643-5. doi:10.1056/NEJMc053092
5. Dammann O, Ferriero D, Gressens P. Neonatal encephalopathy or hypoxic-ischemic encephalopathy? Appropriate terminology matters. Pediatr Res (2011) 70:1-2. doi:10.1203/PDR.0b013e318223f38d
6. Leviton A. Why the term neonatal encephalopathy should be preferred over neonatal hypoxic-ischemic encephalopathy. Am J Obstet Gynecol (2012) 208:176-80. doi:10.1016/j.ajog.2012.07.020
7. Blume HK, Loch CM, Li CI. Neonatal encephalopathy and socioeconomic status: population-based case-control study. Arch Pediatr Adolesc Med (2007) 161:663-8. doi:10.1001/archpedi.161.7.663
8. De Vries LS, Van Haastert IC, Benders MJ, Groenendaal F. Myth: cerebral palsy cannot be predicted by neonatal brain imaging. Semin Fetal Neonatal Med (2011) 16:279-87. doi:10.1016/j.siny.2011.04.004
9. Volpe JJ. The encephalopathy of prematurity - brain injury and impaired brain development inextricably intertwined. Semin Pediatr Neurol (2009) 16:167-78. doi:10.1016/j.spen.2009.09.005
10. Macdonald HM, Mulligan JC, Allen AC, Taylor PM. Neonatal asphyxia. I. Relationship of obstetric and neonatal complications to neonatal mortality in 38,405 consecutive deliveries. J Pediatr (1980) 96:898-902. doi:10.1016/S0022-3476(80)80574-9
11. Finer NN, Robertson CM, Richards RT, Pinnell LE, Peters KL. Hypoxic-ischemic encephalopathy in term neonates: perinatal factors and outcome. J Pediatr (1981) 98:112-7. doi:10.1016/S0022-3476(81)80555-0
12. Robertson CM, Finer NN, Grace MG. School performance of survivors of neonatal encephalopathy associated with birth asphyxia at term. J Pediatr (1989) 114:753-60. doi:10.1016/S0022-3476(89)80132-5
13. Raju TN. Ischemic perinatal stroke: challenge and opportunities. Int J Stroke (2008) 3:169-72. doi:10.1111/j.1747-4949.2008.00205.x
14. Khwaja O, Volpe JJ. Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed (2008) 93:F153-61. doi:10.1136/adc.2006.108837
15. Chen HJ, Wei KL, Yao YJ. Multicenter investigation for incidence of periventricular leukomalacia in premature infants in China. Zhongguo Dang Dai Er Ke Za Zhi (2008) 10:686-92.
16. Baud O, D'Allest AM, Lacaze-Masmonteil T, Zupan V, Nedelcoux H, Delaveaucoupet J, et al. The early diagnosis of periventricular leukomalacia in premature infants with positive rolandic sharp waves on serial electroencephalography. J Pediatr (1998) 132:813-7. doi:10.1016/S0022-3476(98)70309-9
17. Olsen P, Paakko E, Vainionpaa L, Pyhtinen J, Jarvelin MR. Magnetic resonance imaging of periventricular leukomalacia and its clinical correlation in children. Ann Neurol (1997) 41:754-61. doi:10.1002/ana.410410611
18. Johnston MV, Fatemi A, Wilson MA, Northington F. Treatment advances in neonatal neuroprotection and neurointensive care. Lancet Neurol (2011) 10:372-82. doi:10.1016/S1474-4422(11)70016-3
19. Hope PL, Reynolds EO. Investigation of cerebral energy metabolism in newborn infants by phosphorus nuclear magnetic resonance spectroscopy. Clin Perinatol (1985) 12:261-75.
20. Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med (2009) 361:1349-58. doi:10.1056/NEJMoa0900854
21. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet (2005) 365:663-70. doi:10.1016/S0140-6736(05)17946-X
22. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med (2005) 353:1574-84. doi:10.1056/NEJMcps050929
23. Rutherford MA, Azzopardi D, Whitelaw A, Cowan F, Renowden S, Edwards AD. Mild hypothermia and the distribution of cerebral lesions in neonates with hypoxic-ischemic encephalopathy. Pediatrics (2005) 116:1001-6. doi:10.1542/peds.2005-0328
24. Stroke Therapy Academic Industry Roundtable (STAIR). Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke (1999) 30:2752-8. doi:10.1161/01.STR.30.12.2752
25. Stroke Therapy Academic Industry Roundtable II (STAIR-II). Recommendations for clinical trial evaluation of acute stroke therapies. Stroke (2001) 32:1598-606. doi:10.1161/01.STR.32.7.1598
26. Feuerstein GZ, Zaleska MM, Krams M, Wang X, Day M, Rutkowski JL, et al. Missing steps in the STAIR case: a translational medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke. J Cereb Blood Flow Metab (2008) 28:217-9. doi:10.1038/sj.jcbfm.9600516
27. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke (2009) 40:2244-50. doi:10.1161/STROKEAHA.108.541128
28. Chopp M, Steinberg GK, Kondziolka D, Lu M, Bliss TM, Li Y, et al. Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplant (2009) 18:691-3. doi:10.3727/096368909X470883
29. Borlongan CV, Chopp M, Steinberg GK, Bliss TM, Li Y, Lu M, et al. Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med (2008) 3:249-50. doi:10.2217/17460751.3.3.249
30. Borlongan CV. Cell therapy for stroke: remaining issues to address before embarking on clinical trials. Stroke (2009) 40:S146-8. doi:10.1161/STROKEAHA.108.533091
31. Wechsler L, Steindler D, Borlongan C, Chopp M, Savitz S, Deans R, et al. Stem cell therapies as an emerging paradigm in stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke (2009) 40:510-5. doi:10.1161/STROKEAHA.108.526863
32. Borlongan CV, Weiss MD. Baby STEPS: a giant leap for cell therapy in neonatal brain injury. Pediatr Res (2011) 70:3-9. doi:10.1038/pr.2011.228
33. Northington FJ. Brief update on animal models of hypoxic-ischemic encephalopathy and neonatal stroke. ILAR J (2006) 47:32-8. doi:10.1093/ilar.47.1.32
34. Vannucci RC, Vannucci SJ. Perinatal hypoxic-ischemic brain damage: evolution of an animal model. Dev Neurosci (2005) 27:81-6. doi:10.1159/000085978
35. Ditelberg JS, Sheldon RA, Epstein CJ, Ferriero DM. Brain injury after perinatal hypoxia-ischemia is exacerbated in copper/zinc superoxide dismutase transgenic mice. Pediatr Res (1996) 39:204-8. doi:10.1203/00006450-199602000-00003
36. Sheldon RA, Sedik C, Ferriero DM. Strain-related brain injury in neonatal mice subjected to hypoxia-ischemia. Brain Res (1998) 810:114-22. doi:10.1016/S0006-8993(98)00892-0
37. Fullerton HJ, Ditelberg JS, Chen SF, Sarco DP, Chan PH, Epstein CJ, et al. Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann Neurol (1998) 44:357-64. doi:10.1002/ana.410440311
38. Graham EM, Sheldon RA, Flock DL, Ferriero DM, Martin LJ, O'Riordan DP, et al. Neonatal mice lacking functional Fas death receptors are resistant to hypoxic-ischemic brain injury. Neurobiol Dis (2004) 17:89-98. doi:10.1016/j.nbd.2004.05.007
39. Hagberg H, Wilson MA, Matsushita H, Zhu C, Lange M, Gustavsson M, et al. PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. J Neurochem (2004) 90:1068-75. doi:10.1111/j.1471-4159.2004.02547.x
40. Yoles E, Zarchin N, Mayevsky A. Effects of age on the metabolic, ionic and electrical response to anoxia in the newborn dog brain in vivo. J Basic Clin Physyol Pharmacol (1991) 2:297-313. doi:10.1515/JBCPP.1991.2.4.297
41. McQuillen PS, Sheldon RA, Shatz CJ, Ferriero DM. Selective vulnerability of subplate neurons after early neonatal hypoxia-ischemia. J Neurosci (2003) 23:3308-15.
42. Wang S, Wu EX, Cai K, Lau HF, Cheung PT, Khong PL. Mild hypoxic-ischemic injury in the neonatal rat brain: longitudinal evaluation of white matter using diffusion tensor MR imaging. AJNR Am J Neuroradiol (2009) 30:1907-13. doi:10.3174/ajnr.A1697
43. Huang Z, Liu J, Cheung PY, Chen C. Long-term cognitive impairment and myelination deficiency in a rat model of perinatal hypoxic-ischemic brain injury. Brain Res (2009) 1301:100-9. doi:10.1016/j.brainres.2009.09.006
44. Wang S, Wu EX, Tam CN, Lau HF, Cheung PT, Khong PL. Characterization of white matter injury in a hypoxic-ischemic neonatal rat model by diffusion tensor MRI. Stroke (2008) 39:2348-53. doi:10.1161/STROKEAHA.107.509927
45. Chang YC, Huang CC, Hung PL, Huang HM. Rolipram, a phosphodiesterase type IV inhibitor, exacerbates periventricular white matter lesions in rat pups. Pediatr Res (2008) 64:234-9. doi:10.1203/PDR.0b013e31817cfc87
46. Wen TC, Rogido M, Peng H, Genetta T, Moore J, Sola A. Gender differences in long-term beneficial effects of erythropoietin given after neonatal stroke in postnatal day-7 rats. Neuroscience (2006) 139:803-11. doi:10.1016/j.neuroscience.2006.02.057
47. Hurn PD, Vannucci SJ, Hagberg H. Adult or perinatal brain injury: does sex matter? Stroke (2005) 36:193-5. doi:10.1161/01.STR.0000153064.41332.f6
48. Edwards RG. Stem cells today: B1. Bone marrow stem cells. Reprod Biomed Online (2004) 9:541-83. doi:10.1016/S1472-6483(10)61639-2
49. Dewing P, Shi T, Horvath S, Vilain E. Sexually dimorphic gene expression in mouse brain precedes gonadal differentiation. Mol Brain Res (2003) 118:82-90. doi:10.1016/S0169-328X(03)00339-5
50. Carruth LL, Reisert I, Arnold AP. Sex chromosome genes directly affect brain sexual differentiation. Nat Neurosci (2002) 5:933-4. doi:10.1038/nn922
51. Ifudu O, Uribarri J, Rajwani I, Vlacich V, Reydel K, Delosreyes G, et al. Gender modulates responsiveness to recombinant erythropoietin. Am J Kidney Dis (2001) 38:518-22. doi:10.1053/ajkd.2001.26842
52. Zeng SM, Yankowitz J, Widness JA, Strauss RG. Etiology of differences in hematocrit between males and females: sequence-based polymorphisms in erythropoietin and its receptor. J Gend Specif Med (2001) 4:35-40.
53. Guo TL, Germolec DR, Musgrove DL, Delclos KB, Newbold RR, Weis C, et al. Myelotoxicity in genistein-, nonylphenol-, methoxychlor-, vinclozolin- or ethinyl estradiol-exposed F1 generations of Sprague-Dawley rats following developmental and adult exposures. Toxicology (2005) 211:207-19. doi:10.1016/j.tox.2005.03.008
54. Pequignot JM, Spielvogel H, Caceres E, Rodriguez A, Sempore B, Pequignot J, et al. Influence of gender and endogenous sex steroids on catecholaminergic structures involved in physiological adaptation to hypoxia. Pflugers Arch (1997) 433:580-6. doi:10.1007/s004240050317
55. Raju TN. Some animal models for the study of perinatal asphyxia. Biol Neonate (1992) 62:202-14. doi:10.1159/000243873
56. Bjorkman ST, Miller SM, Rose SE, Burke C, Colditz PB. Seizures are associated with brain injury severity in a neonatal model of hypoxia-ischemia. Neuroscience (2010) 166:157-67. doi:10.1016/j.neuroscience.2009.11.067
57. Zhang D, Hathi M, Yang ZJ, Ding H, Koehler R, Thakor N. Hypoxic-ischemic brain injury in neonatal piglets with different histological outcomes: an amplitude-integrated EEG study. Conf Proc IEEE Eng Med Biol Soc (2009) 2009:1127-30. doi:10.1109/IEMBS.2009.5333439
58. Yager JY, Ashwal S. Animal models of perinatal hypoxic-ischemic brain damage. Pediatr Neurol (2009) 40:156-67. doi:10.1016/j.pediatrneurol.2008.10.025
59. Tai WC, Burke KA, Dominguez JF, Gundamraj L, Turman JE Jr. Growth deficits in a postnatal day 3 rat model of hypoxic-ischemic brain injury. Behav Brain Res (2009) 202:40-9. doi:10.1016/j.bbr.2009.03.043
60. Derrick M, Luo NL, Bregman JC, Jilling T, Ji X, Fisher K, et al. Preterm fetal hypoxia-ischemia causes hypertonia and motor deficits in the neonatal rabbit: a model for human cerebral palsy? J Neurosci (2004) 24:24-34. doi:10.1523/JNEUROSCI.2816-03.2004
61. Laptook AR, Corbett RJ, Burns D, Sterett R. Neonatal ischemic neuroprotection by modest hypothermia is associated with attenuated brain acidosis. Stroke (1995) 26:1240-6. doi:10.1161/01.STR.26.7.1240
62. Iwata O, Iwata S, Thornton JS, De Vita E, Bainbridge A, Herbert L, et al. "Therapeutic time window" duration decreases with increasing severity of cerebral hypoxia-ischaemia under normothermia and delayed hypothermia in newborn piglets. Brain Res (2007) 1154:173-80. doi:10.1016/j.brainres.2007.03.083
63. Hess DC, Borlongan CV. Stem cells and neurological diseases. Cell Prolif (2008) 41(Suppl 1):94-114. doi:10.1111/j.1365-2184.2008.00486.x
64. Hess DC, Borlongan CV. Cell-based therapy in ischemic stroke. Expert Rev Neurother (2008) 8:1193-201. doi:10.1586/14737175.8.8.1193
65. Van Velthoven CTJ, Kavelaars A, van Bel F, Heijnen CJ. Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. J Neurosci (2010) 30:9603-11. doi:10.1523/JNEUROSCI.1835-10.2010
66. Borlongan CV, Stahl CE, Cameron DF, Saporta S, Freeman TB, Cahill DW, et al. CNS immunological modulation of neural graft rejection and survival. Neurol Res (1996) 18:297-304.
67. Borlongan CV, Koutouzis TK, Jorden JR, Martinez R, Rodriguez AI, Poulos SG, et al. Neural transplantation as an experimental treatment modality for cerebral ischemia. Neurosci Biobehav Rev (1997) 21:79-90. doi:10.1016/0149-7634(95)00063-1
68. Borlongan CV, Tajima Y, Trojanowski JQ, Lee VM, Sanberg PR. Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp Neurol (1998) 149:310-21. doi:10.1006/exnr.1997.6730
69. Kondziolka D, Wechsler L, Goldstein S, Meltzer C, Thulborn KR, Gebel J, et al. Transplantation of cultured human neuronal cells for patients with stroke. Neurology (2000) 55:565-9. doi:10.1212/WNL.55.4.565
70. Nelson PT, Kondziolka D, Wechsler L, Goldstein S, Gebel J, DeCesare S, et al. Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation. Am J Pathol (2002) 160:1201-6. doi:10.1016/S0002-9440(10)62546-1
71. Borlongan CV, Lind JG, Dillon-Carter O, Yu G, Hadman M, Cheng C, et al. Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Res (2004) 1010:108-16. doi:10.1016/j.brainres.2004.02.072
72. Newman MB, Misiuta I, Willing AE, Zigova T, Karl RC, Borlongan CV, et al. Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells. Stem Cells Dev (2005) 14:29-43. doi:10.1089/scd.2005.14.29
73. Hara K, Matsukawa N, Yasuhara T, Xu L, Yu G, Maki M, et al. Transplantation of post-mitotic human neuroteratocarcinoma-overexpressing Nurr1 cells provides therapeutic benefits in experimental stroke: in vitro evidence of expedited neuronal differentiation and GDNF secretion. J Neurosci Res (2007) 85:1240-51. doi:10.1002/jnr.21234
74. Hara K, Yasuhara T, Maki M, Matsukawa N, Masuda T, Yu SJ, et al. Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke. Prog Neurobiol (2008) 85:318-34. doi:10.1016/j.pneurobio.2008.04.005
75. Yu G, Fournier C, Hess DC, Borlongan CV. Transplantation of carotid body cells in the treatment of neurological disorders. Neurosci Biobehav Rev (2005) 28:803-10. doi:10.1016/j.neubiorev.2004.09.011
76. Sun J, Allison J, McLaughlin C, Sledge L, Waters-Pick B, Wease S, et al. Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders. Transfusion (2010) 50:1980-7. doi:10.1111/j.1537-2995.2010.02720.x
77. Portmann-Lanz CB, Schoeberlein A, Huber A, Sager R, Malek A, Holzgreve W, et al. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol (2006) 194:664-73. doi:10.1016/j.ajog.2006.01.101
78. Nishino H, Borlongan CV. Restoration of function by neural transplantation in the ischemic brain. Prog Brain Res (2000) 127:461-76. doi:10.1016/S0079-6123(00)27022-2
79. Matsukawa N, Yasuhara T, Hara K, Xu L, Maki M, Yu G, et al. Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke. BMC Neurosci (2009) 10:126. doi:10.1186/1471-2202-10-126
80. Robertson CM, Finer NN. Long-term follow-up of term neonates with perinatal asphyxia. Clin Perinatol (1993) 20:483-500.
81. Lauterbach MD, Raz S, Sander CJ. Neonatal hypoxic risk in preterm birth infants: the influence of sex and severity of respiratory distress on cognitive recovery. Neuropsychology (2001) 15:411-20. doi:10.1037/0894-4105.15.3.411
82. Espy KA, Senn TE, Charak DA, Tyler J, Wiebe SA. Perinatal pH and neuropsychological outcomes at age 3 years in children born preterm: an exploratory study. Dev Neuropsychol (2007) 32:669-82. doi:10.1080/87565640701376003
83. Kaandorp JJ, Benders MJ, Rademaker CM, Torrance HL, Oudjik MA, Haan TR, et al. Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-trial); a randomized double blind placebo controlled multicenter study. BMC Pregnancy Childbirth (2010) 10:8. doi:10.1186/1471-2393-10-8
84. Hobbs C, Thoresen M, Tucker A, Aquilina K, Chakkarapani E, Dingley J. Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia. Stroke (2008) 39:1307-13. doi:10.1161/STROKEAHA.107.499822
85. Carroll JE, Borlongan CV. Adult stem cell therapy for acute brain injury in children. CNS Neurol Disord Drug Targets (2008) 7:361-9. doi:10.2174/187152708786441812
86. Kim CT, Han J, Kim H. Pediatric stroke recovery: a descriptive analysis. Arch Phys Med Rehabil (2009) 90:657-62. doi:10.1016/j.apmr.2008.10.016
87. Yasuhara T, Hara K, Maki M, Mays RW, Hess DC, Carroll JE, et al. Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats. J Cereb Blood Flow Metab (2008) 28:1804-10. doi:10.1038/jcbfm.2008.68
88. Yasuhara T, Borlongan CV, Date I. Ex vivo gene therapy: transplantation of neurotrophic factor-secreting cells for cerebral ischemia. Front Biosci (2006) 11:760-75. doi:10.2741/1834
89. Yasuhara T, Matsukawa N, Yu G, Xu L, Mays RW, Kovach J, et al. Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant (2006) 15:231-8. doi:10.3727/000000006783982034
90. Parolini O, Alviano F, Bergwerf I, Boraschi D, De Bari C, De Waele P, et al. Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table. Stem Cells Dev (2010) 19:143-54. doi:10.1089/scd.2009.0404
91. Ashwal S, Obenaus A, Snyder EY. Neuroimaging as a basis for rational stem cell therapy. Pediatr Neurol (2009) 40:227-36. doi:10.1016/j.pediatrneurol.2008.09.025
92. Chau V, Poskitt KJ, Miller SP. Advanced neuroimaging techniques for the term newborn with encephalopathy. Pediatr Neurol (2009) 40:181-8. doi:10.1016/j.pediatrneurol.2008.09.012
93. Agrawal N, Johnston SC, Wu YW, Sidney S, Fullerton HJ. Imaging data reveal a higher pediatric stroke incidence than prior US estimates. Stroke (2009) 40:3415-21. doi:10.1161/STROKEAHA.109.564633
94. Hoehn M, Wiedermann D, Justicia C, Ramos-Cabrer P, Kruttwig K, Farr T, et al. Cell tracking using magnetic resonance imaging. J Physiol (2007) 584:25-30. doi:10.1113/jphysiol.2007.139451
95. Modo M, Mellodew K, Cash D, Fraser SE, Meade TJ, Price J, et al. Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage (2004) 21:311-7. doi:10.1016/j.neuroimage.2003.08.030
96. Jendelova P, Herynek V, Urdzikova L, Glogarova K, Kroupova J, Andersson B, et al. Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res (2004) 76:232-43. doi:10.1002/jnr.20041
97. Shyu WC, Chen CP, Lin SZ, Lee YJ, Li H. Efficient tracking of non-iron-labeled mesenchymal stem cells with serial MRI in chronic stroke rats. Stroke (2007) 38:367-74. doi:10.1161/01.STR.0000254463.24655.14
98. Song M, Kim Y, Ryu S, Song I, Kim SU, Yoon BW. MRI tracking of intravenously transplanted human neural stem cells in rat focal ischemia model. Neurosci Res (2009) 64:235-9. doi:10.1016/j.neures.2009.03.006
99. Daadi MM, Li Z, Arac A, Grueter BA, Sofilos M, Malenka RC, et al. Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Mol Ther (2009) 17:1282-91. doi:10.1038/mt.2009.104
100. Lee ES, Chan J, Shuter B, Tan LG, Chong MS, Ramachandra DL, et al. Microgel iron oxide nanoparticles for tracking human fetal mesenchymal stem cells through magnetic resonance imaging. Stem Cells (2009) 27:1921-31. doi:10.1002/stem.112
101. Tajiri N, Kaneko Y, Shinozuka K, Ishikawa H, Yankee E, McGrogan M, et al. Stem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain site. PLoS One (2013) 8:e74857. doi:10.1371/journal.pone.0074857
102. Sharma A, Sane H, Gokulchandran N, Badhe P, Paranjape K, Paranjape A. Stem cell therapy for cerebral palsy - a novel option. In: Svaraka E, editor. Cerebral Palsy - Challenges for the Future. InTechOpen (2014). Available from: http://www.intechopen.com/books/cerebral-palsy-challenges-for-the-future/stem-cell-therapy-for-cerebral-palsy-a-novel-option
103. ClinicalTrials.gov. Available from: http://clinicaltrials.gov/ct2/results?term=stem+cells+AND+cerebral+palsy&Search=Search (2014)
104. Liao Y, Cotten M, Tan S, Kurtzberg J, Cairo MS. Rescuing the neonatal brain from hypoxic injury with autologous cord blood. Bone Marrow Transplant (2012) 48:890-900. doi:10.1038/bmt.2012.169
105. Li M, Yu A, Zhang F, Dai G, Cheng H, Wang X, et al. Treatment of one case of cerebral palsy combined with posterior visual pathway injury using autologous bone marrow mesenchymal stem cells. J Transl Med (2012) 10:100. doi:10.1186/1479-5876-10-100
106. Jordan LC, Rafay MF, Smith SE, Askalan R, Zamel KM, deVeber G, et al. Antithrombotic treatment in neonatal cerebral sinovenous thrombosis: results of the International Pediatric Stroke Study. J Pediatr (2010) 156:704-10. doi:10.1016/j.jpeds.2009.11.061
107. Grunwald IQ, Walter S, Shamdeen MG, Dautermann A, Roth C, Haass A, et al. New mechanical recanalization devices - the future in pediatric stroke treatment? J Invasive Cardiol (2010) 22:63-6.
108. Normann S, De Veber G, Fobker M, Langer C, Kenet G, Bernanrd TJ, et al. Role of endogenous testosterone concentration in pediatric stroke. Ann Neurol (2009) 66:754-8. doi:10.1002/ana.21840
109. Kenet G, Lutkhoff LK, Albisetti M, Bernanrd T, Bonduel M, Brandao L, et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation (2010) 121:1838-47. doi:10.1161/CIRCULATIONAHA.109.913673
110. Ganesan V. Pediatric stroke guidelines: where will these take future research and treatment options for childhood stroke? Expert Rev Neurother (2009) 9:639-48. doi:10.1586/ern.09.14
111. Amlie-Lefond C, Bernard TJ, Sebire G, Friedman NR, Heyer GL, Lerner NB, et al. Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study. Circulation (2009) 119:1417-23. doi:10.1161/CIRCULATIONAHA.108.806307
112. Berman DR, Liu Y, Barks J, Mozurkewich E. Treatment with docosahexaenoic acid after hypoxia-ischemia improves forepaw placing in a rat model of perinatal hypoxia-ischemia. Am J Obstet Gynecol (2010) 203:381-5. doi:10.1016/j.ajog.2010.06.017
113. Zhou Y, Fathali N, Lekic T, Ostrowski RP, Chen C, Martin RD, et al. Remote limb ischemic postconditioning protects against neonatal hypoxic-ischemic brain injury in rat pups by the opioid receptor/Akt pathway. Stroke (2011) 42:439-44. doi:10.1161/STROKEAHA.110.592162
114. Shankaran S, Laptook A, Wright LL, Ehrenkranz RA, Donovan EF, Fanaroff AA, et al. Whole-body hypothermia for neonatal encephalopathy: animal observations as a basis for a randomized, controlled pilot study in term infants. Pediatrics (2002) 110:377-85. doi:10.1542/peds.110.2.377
115. Lei B, Tan X, Cai H, Xu Q, Guo Q. Effect of moderate hypothermia on lipid peroxidation in canine brain tissue after cardiac arrest and resuscitation. Stroke (1994) 25:147-52. doi:10.1161/01.STR.25.1.147
116. Thoresen M, Penrice J, Lorek A, Cady EB, Wylezinska M, Kirkbride V, et al. Mild hypothermia after severe transient hypoxia-ischemia ameliorates delayed cerebral energy failure in the newborn piglet. Pediatr Res (1995) 37:667-70. doi:10.1203/00006450-199505000-00019
117. Battin MR, Dezoete JA, Gunn TR, Gluckman PD, Gunn AJ. Neurodevelopmental outcome of infants treated with head cooling and mild hypothermia after perinatal asphyxia. Pediatrics (2001) 107:480-4. doi:10.1542/peds.107.3.480
118. Battin MR, Penrice J, Gunn TR, Gunn AJ. Treatment of term infants with head cooling and mild systemic hypothermia (35.0 degrees C and 34.5 degrees C) after perinatal asphyxia. Pediatrics (2003) 111:244-51. doi:10.1542/peds.111.2.244
119. Bergstedt K, Hu BR, Wieloch T. Postischaemic changes in protein synthesis in the rat brain: effects of hypothermia. Exp Brain Res (1993) 95:91-9. doi:10.1007/BF00229658
120. Tagin MA, Woolcott CG, Vincer MJ, Whyte RK, Stinson DA. Hypothermia for neonatal hypoxic ischemic encephalopathy: an updated systematic review and meta-analysis. Arch Pediatr Adolesc Med (2012) 166:558-66. doi:10.1001/archpediatrics.2011.1772
121. Pavel Gonzalez-Ibarra F, Varon J, Lopez-Meza EG. Therapeutic hypothermia: critical review of the molecular mechanism of action. Front Neurol (2011) 2:4. doi:10.3389/fneur.2011.00004
122. Deng W, Aimone JB, Gage FH. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci (2010) 11:339-50. doi:10.1038/nrn2822
123. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci (2011) 12:723-38. doi:10.1038/nrn3114
124. Yenari M, Kitagawa K, Lyden P, Perez-Pinzon M. Metabolic downregulation: a key to successful neuroprotection? Stroke (2008) 39:2910-7. doi:10.1161/STROKEAHA.108.514471
125. Robertson NJ, Nakakeeto M, Hagmann C, Cowan FM, Acolet D, Iwata O, et al. Therapeutic hypothermia for birth asphyxia in low-resource settings: a pilot randomised controlled trial. Lancet (2008) 372:801-3. doi:10.1016/S0140-6736(08)61329-X
126. Glass HC, Nash KB, Bonifacio SL, Barkovich AJ, Ferriero DM, Sullivan JE, et al. Seizures and magnetic resonance imaging-detected brain injury in newborns cooled for hypoxic-ischemic encephalopathy. J Pediatr (2011) 159: 731-5.e1. doi:10.1016/j.jpeds.2011.07.015
127. Higgins RD, Raju T, Edwards AD, Azzopardi DV, Bose CL, Clark RH, et al. Hypothermia and other treatment options for neonatal encephalopathy: an executive summary of the Eunice Kennedy Shriver NICHD workshop. J Pediatr (2011) 159(851-858):e851. doi:10.1016/j.jpeds.2011.08.004
128. Jatana M, Singh I, Singh AK, Jenkins D. Combination of systemic hypothermia and N-acetylcysteine attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res (2006) 59:684-9. doi:10.1203/01.pdr.0000215045.91122.44
129. Jenkins DD, Chang E, Singh I. Neuroprotective interventions: is it too late? J Child Neurol (2009) 24:1212-9. doi:10.1177/0883073809338412
130. Wu YW, Bauer LA, Ballard RA, Ferriero DM, Glidden DV, Mayock DE, et al. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics. Pediatrics (2012) 130:683-91. doi:10.1542/peds.2012-0498
131. Xiong T, Qu Y, Mu D, Ferriero D. Erythropoietin for neonatal brain injury: opportunity and challenge. Int J Dev Neurosci (2011) 29:583-91. doi:10.1016/j.ijdevneu.2010.12.007
132. Dickinson R, Franks NP. Bench-to-bedside review: molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection. Crit Care (2010) 14:229. doi:10.1186/cc9051
133. Ferriero DM. Neonatal brain injury. N Engl J Med (2004) 351:1985-95. doi:10.1056/NEJMra041996
134. Bonifacio SL, Glass HC, Peloquin S, Ferriero DM. A new neurological focus in neonatal intensive care. Nat Rev Neurol (2011) 7:485-94. doi:10.1038/nrneurol.2011.119
135. Borlongan CV, Glover LE, Tajiri N, Kaneko Y, Freeman TB. The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders. Prog Neurobiol (2011) 95:213-28. doi:10.1016/j.pneurobio.2011.08.005
136. Borlongan CV, Kaneko Y, Maki M, Yu SJ, Ali M, Allickson JG, et al. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev (2010) 19:439-52. doi:10.1089/scd.2009.0340
137. Ozawa K, Sato K, Oh I, Ozaki K, Uchibori R, Obara Y, et al. Cell and gene therapy using mesenchymal stem cells (MSCs). J Autoimmun (2008) 30:121-7. doi:10.1016/j.jaut.2007.12.008
138. Gunn AJ, Gunn TR. The "pharmacology" of neuronal rescue with cerebral hypothermia. Early Hum Dev (1998) 53:19-35. doi:10.1016/S0378-3782(98)00033-4
139. Iadecola C, Anrather J. Stroke research at a crossroad: asking the brain for directions. Nat Neurosci (2011) 14:1363-8. doi:10.1038/nn.2953
140. Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M, et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ (2010) 340:c363. doi:10.1136/bmj.c363
141. Shalak L, Perlman JM. Hypoxic-ischemic brain injury in the term infant-current concepts. Early Hum Dev (2004) 80:125-41. doi:10.1016/j.earlhumdev.2004.06.003
142. Goñi de Cerio F, Lara-Celador I, Alvarez A, Hilario E. Neuroprotective therapies after perinatal hypoxic-ischemic brain injury. Brain Sci (2013) 3:191-214. doi:10.3390/brainsci3010191
143. Sims B. Neuroprotective strategies in neonatal brain injury. Pediat Therapeut (2012) 2:e117. doi:10.4172/2161-0665.1000e117
144. Carrascosa-Romero MC, De Cabo-de la Vega C. Neuroprotection in perinatal hypoxic-ischemic encephalopathy - pharmacologic combination therapy. In: Švraka E, editor. Cerebral Palsy - Challenges for the Future. Rijeka, Croatia: InTech (2014). p. 123-92.
145. Zhuang L, Yang T, Zhao H, Fidalgo AR, Vizcaychipi M, Sanders RD, et al. The protective profile of argon, helium, and xenon in a model of neonatal asphycia in rats. Crit Care Med (2012) 40:1724-30. doi:10.1097/CCM.0b013e3182452164
146. Boutin H, Dauphin F, Mackenzie ET, Jauzac P. Differential time-course decreases in nonselective, mu-, delta-, and kappa-opioid receptors after focal cerebral ischemia in mice. Stroke (1999) 30:1271-8. doi:10.1161/01.STR.30.6.1271
147. Kevelaitis E, Peynet J, Mouas C, Launay JM, Menasche P. Opening of potassium channels: the common cardioprotective link between preconditioning and natural hibernation? Circulation (1999) 99:3079-85. doi:10.1161/01.CIR.99.23.3079
148. Tsai SY, Lee CT, Hayashi T, Freed WJ, Su TP. Delta opioid peptide DADLE and naltrexone cause cell cycle arrest and differentiation in a CNS neural progenitor cell line. Synapse (2010) 64:267-73. doi:10.1002/syn.20727
149. Borlongan CV, Su TP, Wang Y. Treatment with delta opioid peptide enhances in vitro and in vivo survival of rat dopaminergic neurons. Neuroreport (2000) 11:923-6. doi:10.1097/00001756-200004070-00005
150. Kaneko Y, Tajiri N, Su TP, Wang Y, Borlongan CV. Combination treatment of hypothermia and mesenchymal stromal cells amplifies neuroprotection in primary rat neurons exposed to hypoxic-ischemic-like injury in vitro: role of the opioid system. PLoS One (2012) 7:e47583. doi:10.1371/journal.pone.0047583
151. Young MN, Hollenbeck RD, Pollock JS, McPherson JA, Fredi JL, Piana RM. Effectiveness of mild therapeutic hypothermia following cardiac arrest in adult patients with congenital heart disease. Am J Cardiol (2014) 114:128-30. doi:10.1016/j.amjcard.2014.04.012
152. Crossley S, Reid J, McLatchie R, Hayton J, Clark C, MacDougal M, et al. A systematic review of therapeutic hypothermia for adult patients following traumatic brain injury. Crit Care (2014) 18:R75. doi:10.1186/cc13835
153. Batchelor PE, Skeers P, Antonic A, Wills TE, Howells DW, Macleod MR, et al. Systematic review and meta-analysis of therapeutic hypothermia in animal models of spinal cord injury. PLoS One (2013) 8:e71317. doi:10.1371/journal.pone.0071317
154. Tang XN, Liu L, Koike MA, Yenari MA. Mild hypothermia reduces tissue plasminogen activator-related hemorrhage and blood brain barrier disruption after experimental stroke. Ther Hypothermia Temp Manag (2013) 3:74-83. doi:10.1089/ther.2013.0010
155. Marchetto M, Gage FH. Your brain under the microscope: the promise of stem cells. Cerebrum (2014) 2014:1.
156. Barker RA, Jain M, Armstrong RJE, Caldwell MA. Stem cells and neurological disorders. J Neurol Neurosurg Psychiatry (2003) 74:553-7. doi:10.1136/jnnp.74.5.553
157. Borlongan CV, Lind JG, Dillon-Carter O, Yu G, Hadman M, Cheng C, et al. Intracerebral xenografts of mouse bone marrow cells in adult rats facilitate restoration of cerebral blood flow and blood-brain barrier. Brain Res (2004) 1009:26-33. doi:10.1016/j.brainres.2004.02.050
158. Borlongan CV, Hadman M, Sanberg CD, Sanberg PR. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke (2004) 35:2385-9. doi:10.1161/01.STR.0000141680.49960.d7
159. Borlongan CV, Hida H, Nishino H. Early assessment of motor dysfunctions aids in successful occlusion of the middle cerebral artery. Neuroreport (1998) 9:3615-21. doi:10.1097/00001756-199811160-00012